Logo image of BIOS.BR

BIOSENIC SA (BIOS.BR) Stock Price, Quote, News and Overview

EBR:BIOS - Euronext Brussels - BE0974280126 - Common Stock - Currency: EUR

0.003  0 (0%)

BIOS.BR Quote, Performance and Key Statistics

BIOSENIC SA

EBR:BIOS (3/7/2025, 7:00:00 PM)

0.003

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High0.04
52 Week Low0
Market Cap1.41M
Shares469.69M
Float411.54M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-26 2025-05-26
IPO02-06 2015-02-06


BIOS.BR short term performance overview.The bars show the price performance of BIOS.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

BIOS.BR long term performance overview.The bars show the price performance of BIOS.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of BIOS.BR is 0.003 EUR. In the past month the price decreased by -11.76%. In the past year, price decreased by -90%.

BIOSENIC SA / BIOS Daily stock chart

BIOS.BR Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 21.07 346.68B
1ABBV.MI ABBVIE INC 20.82 342.48B
AMG.DE AMGEN INC 16.43 161.21B
1AMGN.MI AMGEN INC 15.84 160.89B
1GILD.MI GILEAD SCIENCES INC 25.67 135.84B
GIS.DE GILEAD SCIENCES INC 25.39 134.40B
VX1.DE VERTEX PHARMACEUTICALS INC 1667.04 115.58B
ARGX.BR ARGENX SE 253.61 33.75B
22UA.DE BIONTECH SE-ADR N/A 24.36B
IDP.DE BIOGEN INC 9.25 20.54B
1BIIB.MI BIOGEN INC 8.39 19.21B
0QF.DE MODERNA INC N/A 13.19B

About BIOS.BR

Company Profile

BIOS logo image BioSenic SA is a biotech company engages in the development of clinical assets . The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 11 full-time employees. The company went IPO on 2015-02-06. The firm develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. The company is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration. The company also provides cell therapy platform for tissue repair protection with an entirely new arsenal of various anti-inflammatory and anti-autoimmune formulations using the immunomodulatory properties of ATO/OATO (Arsenic trioxide/ Oral arsenic trioxide).

Company Info

BIOSENIC SA

Rue Granbonpre 11, Batiment H (bte 24)

Mont-Saint-Guibert BRABANT-WALLON BE

Employees: 11

Company Website: http://www.bonetherapeutics.com/

Investor Relations: https://www.biosenic.com/investors

Phone: 32493097366

BIOSENIC SA / BIOS.BR FAQ

What is the stock price of BIOSENIC SA today?

The current stock price of BIOS.BR is 0.003 EUR.


What is the ticker symbol for BIOSENIC SA stock?

The exchange symbol of BIOSENIC SA is BIOS and it is listed on the Euronext Brussels exchange.


On which exchange is BIOS.BR stock listed?

BIOS.BR stock is listed on the Euronext Brussels exchange.


What is BIOSENIC SA worth?

BIOSENIC SA (BIOS.BR) has a market capitalization of 1.41M EUR. This makes BIOS.BR a Nano Cap stock.


How many employees does BIOSENIC SA have?

BIOSENIC SA (BIOS.BR) currently has 11 employees.


Should I buy BIOSENIC SA (BIOS.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOSENIC SA (BIOS.BR) stock pay dividends?

BIOS.BR does not pay a dividend.


When does BIOSENIC SA (BIOS.BR) report earnings?

BIOSENIC SA (BIOS.BR) will report earnings on 2025-05-26.


BIOS.BR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BIOS.BR Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

BIOS.BR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 42% to BIOS.BR. The Buy consensus is the average rating of analysts ratings from 9 analysts.


Ownership
Inst Owners3.29%
Ins Owners8.85%
Short Float %N/A
Short RatioN/A
Analysts
Analysts42.22
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A